Calcifediol(Ref.Brand: Rayaldee®(US) Generics

Form: ER Oral Capsule

Strength: 30 mcg

Reference Brands:

Category: Nephrology

Calcifediol, marketed as Rayaldee®, is an extended-release oral vitamin D analog indicated for the treatment of secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency. Approved by the FDA, Rayaldee® gradually increases serum 25(OH)D levels, helping to reduce elevated parathyroid hormone (PTH) levels without causing excessive calcium or phosphorus elevation. It is available as a 30 mcg extended-release capsule, offering convenient once-daily dosing. Calcifediol represents a valuable addition to renal therapeutic portfolios and is an attractive option for B2B licensing, distribution, and commercialization in the expanding nephrology market across regulated regions.